Center for Biotechnology, NYS Center for Advanced Technology

Stony Brook Research News: New Test for Cervical Cancer Tackles Healthcare Inequalities Stony Brook University faculty member and CFB supported researcher, Eric Brouzes, is leading a research to develop new testing methods for cervical cancer that do not require expensive equipment. The project has received a two-year grant of $50K per year from the Prevent Cancer Foundation. Read more about the project on SBU News: https://lnkd.in/dfbyew9D

Stony Brook Venture Challenge?- Apply Today! The Stony Brook Venture (SBV) Challenge is focused on identifying high-potential, impactful cutting-edge hard tech venture concepts originating from research labs and universities on Long Island, accelerating and supporting their commercialization journey to bring impactful, equitable and sustainable solutions and products to market. The SBV Challenge is looking to support champions of hard tech innovations in Energy, Health and Information SBV Challenge participants and winners receive mentorship and incentives to advance their technologies and accelerate their entrepreneurial journey. Learn more and apply here: https://lnkd.in/ezPXrH5p

Andrea Goldsmith Named Seventh President of Stony Brook University Princeton University Dean of Engineering and Applied Science Andrea Goldsmith, PhD, has been named the seventh president of Stony Brook University by The State University of New York Board of Trustees and Chancellor John King. A visionary leader, Dr. Goldsmith brings an extraordinary background as a dean, researcher in engineering, technology company founder, and faculty member at Princeton and previously at Stanford University and Caltech. We look forward to welcoming Dr. Goldsmith to the Stony Brook Community!?\ https://lnkd.in/enzvHfRt

In Memory of Peter Young The Center for Biotechnology is deeply saddened to share the loss of one of our biggest advocates and trusted advisors, Peter Young. Peter spent his career in the life-science industry, most recently as a Sr. Venture Partner and Executive-in- Residence with Pappas Capital. Until recently, he resided on Long Island and gave freely of his time and expertise to support our Center, and the emerging life sciences companies, entrepreneurs, and faculty innovators we work with to advance life science innovation into the market. Most importantly, Peter had a wonderful and kind spirit that he generously shared with all of us. He will be profoundly missed.

CNY Biotech Accelerator’s (CNYBAC) Medical Device Innovation Challenge CNY Biotech Accelerator, Upstate Medical University (CNYBAC) Medical Device Innovation Challenge (MDIC) is a 6-month virtual program mentoring selected early-to-mid stage start-up companies each year. The MDIC serves as a complementary and collaborative initiative to assist teams in preparation for incubation programs, expand their innovation ecosystem, and assess strategic planning by providing mentorship, resources, funding/pitch opportunities, and connections. Teams must be US-based and commercializing a medical device per FDA definition. The initial MDIC Application is accepted January through March 15 each year. Those that fully complete the initial application are sent an Innovation Law Center Supplemental Application to be completed by March 31. Only those applicants that fill out both forms will move on to the selection process. CNYBAC Medical Device Innovation Challenge (MDIC) Two-step Application Process Step 1:?Confirm eligibility Step 2:?Complete Innovation Law Center (ILC) Application Review Form Read full details and apply here:? https://lnkd.in/efATCfu6

StartUps: BMS Golden Ticket Competition - Win One Year at BioLabs NYULangone The 2024 Bristol Myers Squibb Golden Ticket competition is now live and offers incredible opportunities for your startup: - Dedicated lab space in the heart of NYC Biolabs@NYULangone - Unparalleled networking and programming opportunities - Tax-free benefits to accelerate your growth - Access to a vibrant community of innovators Bristol Myers Squibb will select up to two (2) winners. Do not miss this chance to fast-track your milestones! Apply now: https://lnkd.in/ec45rwRN

NHLBI Exploratory Research Grant for Bioengineers A Notice of Special Interest (NOSI) has been issued by the National Heart, Lung, and Blood Institute (NHLBI) to encourage early-stage innovative bioengineering projects that could lead to preclinical and translational research and potential funding from federal and non-federal sources. The program is distinct from the NHLBI Catalyze Program and is focused on investigator-initiated ideas and concepts that may eventually contribute to the Catalyze pipeline. This NOSI invites discovery- and design-driven bioengineering research ideas that are important across the Institute and critical for future hypothesis-generating projects. Notably, this program emphasizes first-generation prototype development and initial feasibility studies. The NHLBI is interested in the development of new ideas for diagnostics, therapeutics, surgical technologies, artificial intelligence/machine learning/computational modeling tools, smart biomaterials for self-adjusting implants, molecular imaging, synthetic biology, and nanotechnologies, as applied to HLBS-related issues. First Available Due Date: February 16, 2025 Read the full NOSI and details on applying here: https://lnkd.in/eZGQAugH

CFB Director Clinton Rubin's research was just published in in JAMA-network: "Low magnitude mechanical signals, delivered using low intensity vibration, protects/builds the skeleton in young women fighting anorexia nervosa." Read more: https://lnkd.in/eP3nC76w The article was also the focus of an editorial from JAMA: https://lnkd.in/eJe7DqEj

Interested in SBIR/STTR Funding??Learn more with?NIH SEED?on 11/13. Hear about open funding opportunities, common application pitfalls and strategies for success.? Learn more and register here: https://lnkd.in/ejihuF8P

Upcoming Webinar: AI-Driven MedTech – Navigating the New Frontier Join MIDI Product Development on Wednesday, November 6th, at 12 PM ET for an exclusive live webinar hosted by AdvaMed where industry leaders will share insights into the transformative role of Artificial Intelligence (AI) in MedTech and healthcare. ?? Key Topics: - AI in Diagnostics and Treatment Planning: Real-world applications and future advancements - AI Automation in MedTech: From data analysis to clinical decision support - AI Integration in Healthcare Systems: Regulatory insights and practical considerations Presenters: Gregory Montalbano Principal at MIDI Medical Product Development Louisa Harvey Founder & Principal at ClariMed, Inc. Learn More & Register Here: https://lnkd.in/gNEpdc_4